Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Shikonin alleviates doxorubicin-induced cardiotoxicity via Mst1/Nrf2 pathway in mice

View through CrossRef
AbstractDoxorubicin (DOX) is a popular and potent anticancer drug, but its cardiotoxicity limits its clinical application. Shikonin has a wide range of biological functions, including antioxidant and anti-inflammatory effects. The aim of this study was to investigate the effects of shikonin on DOX-induced cardiac injury and to identify the underlying mechanisms. Mice receiving shikonin showed reduced cardiac injury response and enhanced cardiac function after DOX administration. Shikonin significantly attenuated DOX-induced oxidative damage, inflammation accumulation and cardiomyocyte apoptosis. Shikonin protects against DOX-induced cardiac injury by inhibiting Mammalian sterile 20-like kinase 1 (Mst1) and oxidative stress and activating the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway. In conclusion, shikonin alleviates DOX-induced cardiotoxicity by inhibiting Mst1 and activating Nrf2. Shikonin may be used to treat DOX-induced cardiac injury.
Title: Shikonin alleviates doxorubicin-induced cardiotoxicity via Mst1/Nrf2 pathway in mice
Description:
AbstractDoxorubicin (DOX) is a popular and potent anticancer drug, but its cardiotoxicity limits its clinical application.
Shikonin has a wide range of biological functions, including antioxidant and anti-inflammatory effects.
The aim of this study was to investigate the effects of shikonin on DOX-induced cardiac injury and to identify the underlying mechanisms.
Mice receiving shikonin showed reduced cardiac injury response and enhanced cardiac function after DOX administration.
Shikonin significantly attenuated DOX-induced oxidative damage, inflammation accumulation and cardiomyocyte apoptosis.
Shikonin protects against DOX-induced cardiac injury by inhibiting Mammalian sterile 20-like kinase 1 (Mst1) and oxidative stress and activating the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway.
In conclusion, shikonin alleviates DOX-induced cardiotoxicity by inhibiting Mst1 and activating Nrf2.
Shikonin may be used to treat DOX-induced cardiac injury.

Related Results

A Stress-Responsive Transcriptional Factor NRF2 Activates Hematopoietic Stem Cells
A Stress-Responsive Transcriptional Factor NRF2 Activates Hematopoietic Stem Cells
Abstract KEAP1-NRF2 system is a major regulator of cellular redox balance and xenobiotic metabolism. NRF2 is an inducible transcription factor, and KEAP1 is its nega...
Shikonin supresses hepatocellular carcinoma by inhibiting JAG1/Notch1/uPA Signaling
Shikonin supresses hepatocellular carcinoma by inhibiting JAG1/Notch1/uPA Signaling
BackgroundShikonin, a bioactive naphthoquinone from Arnebiae Radix, exhibits hepatoprotective properties and anti-coagulation effects via inhibiting urokinase-type plasminogen acti...
GW24-e2975 Over-expression of calpastatin aggravates in vitro and in vivo cardiotoxicity induced by doxorubicin
GW24-e2975 Over-expression of calpastatin aggravates in vitro and in vivo cardiotoxicity induced by doxorubicin
Objectives Doxorubicin often causes damage to the heart, which may present as cardiomyopathy. However, the mechanisms by which doxorubicin induces cardiotoxicity ...
Qingxiong Ointment and its Active Ingredient, Shikonin Treat Psoriasis through HIF-1 Signaling Pathway
Qingxiong Ointment and its Active Ingredient, Shikonin Treat Psoriasis through HIF-1 Signaling Pathway
Background: Psoriasis is a common chronic inflammatory skin disorder. Qingxiong ointment (QX) is a natural medicinal combination frequently employed in clinical treatment of psoria...

Back to Top